I would agree with you, except that Toby has been an on-market buyer of CFO securities on what I would almost call a regular basis since Oct of 2016. Would be nice if other directors from other companies could say the same.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
